Compensation expense for the Company’s share-based plans was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | June 28, 2025 | | June 29, 2024 | | June 28, 2025 | | June 29, 2024 | | Share-based compensation expense included in: | | | | | | | | | Costs of sales | $ | 14 | | | $ | 12 | | | $ | 28 | | | $ | 24 | | | Selling, general and administrative expenses | 40 | | | 35 | | | 75 | | | 64 | | | Research and development expenditures | 20 | | | 16 | | | 37 | | | 31 | | | Share-based compensation expense included in Operating earnings | 74 | | | 63 | | | 140 | | | 119 | | | Tax benefit | (15) | | | (13) | | | (29) | | | (24) | | | Share-based compensation expense, net of tax | $ | 59 | | | $ | 50 | | | $ | 111 | | | $ | 95 | | | Decrease in basic earnings per share | $ | (0.35) | | | $ | (0.30) | | | $ | (0.67) | | | $ | (0.57) | | | Decrease in diluted earnings per share | $ | (0.35) | | | $ | (0.29) | | | $ | (0.66) | | | $ | (0.56) | | | | | | | | | |
|